Study identification

PURI

https://redirect.ema.europa.eu/resource/16444

EU PAS number

EUPAS15749

Study ID

16444

Official title and acronym

Pattern of use of intravitreal drugs with antiangiogenic properties for age-related macular degeneration and other vascular retinopathies (Anti-VEGF drugs)

DARWIN EU® study

No

Study countries

Italy

Study description

This is a drug utilization study of antiVEGF drugs for the treatment of age related macular degeneration and other vascular retinopathies in clinical practice, in the Tuscany region of Italy, from 2011 to 2015

Study status

Finalised
Research institution and networks

Institutions

Contact details

Rosa Gini

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Data collection

Planned:
Actual:

Start date of data analysis

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

Self-funded by ARS
Study protocol
Initial protocol

Pattern of use drugs for AMD treatment_to_publish

English (108.47 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable